.jpg?format=webp&quality=80&width=3840)
The study aimed to identify predictors of declining sexual function among men on active surveillance (AS) for prostate cancer. The study included 554 men enrolled in a clinical registry, and sexual function outcomes were measured at baseline and 12 months postdiagnosis. The results showed that having two or more biopsies after diagnosis, higher number of positive biopsy cores, being in an older age category, having depression, and impaired physical function were significant predictors of decline in sexual function score at 12 months. Greater socioeconomic advantage and year of diagnosis were positively associated with 12-month sexual function score. The study suggests that reducing the number of biopsies through less invasive monitoring approaches, screening for physical and mental well-being, and targeted emotional support and counseling services may be helpful for men on AS.
Like
Save
Share